pharmaphorum

APRIL 8, 2024

Less than half of the cancer therapies given accelerated approval by the FDA in 2013 to 2017 showed a clinical benefit in a confirmatory trial within the next five years

FDA 110

FDA 110

World of DTC Marketing

FEBRUARY 17, 2022

Moreover, localized lung cance r diagnoses rose to 28% in 2018 from 20% in 2013— the year that the U.S. The 5-year survival rate has increased by 6% for distant-stage lung cancer, 33% for a regional-stage disease, and 60% for localized disease.

Medicine 271

Medicine Insurance Leads Medical 271

World of DTC Marketing

NOVEMBER 24, 2021

One-quarter of all cancer patients chose not to fill a prescription due to cost, according to a 2013 study in The Oncologist. According to a study published in the American Journal of Medicine, more than 42 percent of the 9.5 million people diagnosed with cancer from 2000 to 2012 drained their life’s assets within two years.

Food and Drug Administration 266

Food and Drug Administration Insurance Prescription FDA 266

World of DTC Marketing

OCTOBER 6, 2021

The Defense Threat Reduction Agency, a division of the Department of Defense, provided more than $10 million of funding in 2013 and 2015 to Emory University, as research done by the nonprofit Knowledge Ecology International has revealed.

Food and Drug Administration 198

Food and Drug Administration Government Medicine Food 198

MedCity News

OCTOBER 17, 2022

It’s the second partnership between the two companies; an alliance that began in 2013 expired without Gilead licensing any molecules from the deal. Gilead Sciences is betting that a MacroGenics antibody drug for blood cancers can offer a safety edge over others that address the same target.

Safety 102

Safety Biopharma Pharma 102

World of DTC Marketing

AUGUST 9, 2021

HCPs are also connecting more than ever: one study showed that HCP posts about healthcare increased from 10% in 2013 to 50% in 2019. According to Sermo, two-thirds of physicians spend at least an hour on social media, with an average daily use of two hours and twenty-two minutes. 33 Even now, nearly 70% of all HCPs are digital natives.

Media 294

Media Physicians Pharma Marketing 294

European Pharmaceutical Review

FEBRUARY 23, 2024

Richard Gonzalez will retire as the company’s CEO to become Executive Chairman, having served as the company’s CEO since its launch in 2013, AbbVie noted. Richard has facilitated AbbVie securing a market capitalisation increase from $54 billion in 2013 to over $300 billion in 2024.

Marketing 97

Marketing Leads Medical Pharmaceutical 97

World of DTC Marketing

MARCH 28, 2021

However, despite the momentum the bill has gained throughout the years, the Treat and Reduce Obesity Act (commonly known as TROA) has yet to come up for a committee or floor vote since it was first introduced in 2013. It needs to be passed NOW but even this won’t be enough.

Doctors 250

Doctors Patients Insurance Physicians 250

World of DTC Marketing

SEPTEMBER 7, 2022

household income from 2009 to 2013 was $53,046, according to the United States Census Bureau, but many of the most recently approved anticancer treatments approved by the United States Food and Drug Administration (FDA) are priced well above $100,000 per year. ASH Clinical News takes it a step further.

Pharma 210

Pharma Food and Drug Administration Marketing Prescription 210

World of DTC Marketing

AUGUST 19, 2022

A Journal of the American Medical Association ( JAMA ) study investigated how five key factors were associated with healthcare increases from 1996 to 2013: Service price and intensity Population growth Population aging Disease prevalence or incidence Medical service utilization.

Healthcare 204

Healthcare Healthcare Insurance Competition 204

World of DTC Marketing

JUNE 4, 2021

” Roughly 40% of all US cases of incident diabetes during 2013-2016 were directly attributable to obesity , a finding that further solidifies the major etiologic role for obesity in the current American diabetes epidemic. Fewer than 10 percent of American adults ate enough vegetables in 2013. Dr. Natalie A.

Food 207

Food Insurance Leads Medical 207

World of DTC Marketing

MAY 19, 2021

billion on R&D from 2013 to 2018. In January, Fortune reported AbbVie would raise the price of Humira by 7.4%. Why the increase? Drugmakers often claim higher prices are needed to fund research and development. AbbVie spent a total of $2.45 Porter (D-Calif.) pointed out that the company spends nearly double that—$4.7

Pharma 181

Pharma Prescription Patients Pharmaceutical 181

Pharmaceutical Technology

MARCH 12, 2024

Butterworth Laboratories looks at the current amino acid testing landscape since the changes in monographs introduced in 2013.

52

52

European Pharmaceutical Review

JULY 5, 2023

Having been originally published in 2007, then revised in 2013, this latest 2023 edition addresses evolving standards and container types.

Manufacturing 96

Manufacturing Pharmaceutical manufacturing Pharmaceutical products Pharmaceutical 96

European Pharmaceutical Review

MARCH 11, 2024

An earlier case of contamination from 2013 of manufactured steroid injections containing methylprednisolone acetate was also mentioned in the paper. The authors stated that the presence of Aspergillus penicillioides in antimicrobial preoperative skin preparation drugs were attributed to inadequate storage conditions.

Pharmaceutical 98

Pharmaceutical Food and Drug Administration Manufacturing Pharmaceutical products 98

European Pharmaceutical Review

SEPTEMBER 26, 2022

Construction at the Carrigtwohill facility built in 2013 is set to begin in 2023. AbbVie , an international R&D biopharmaceutical enterprise has celebrated its 20th anniversary by investing in extensive renovations at its manufacturing site in Cork, Ireland.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Biopharma Engineering 98

European Pharmaceutical Review

AUGUST 30, 2022

The report, Clinical Trials – The Importance of Diversity in Clinical Trials , examined data from clinical trials initiated between 1 January 2013 and 16 June 2022. Diversity within the pharmaceutical sector and clinical trials continues to be a problem, according to a recent report by data and analytics company GlobalData.

Food and Drug Administration 97

Food and Drug Administration Food Safety Pharmaceutical 97

PharmExec

JULY 7, 2022

In episode 112, Nima Farzan, CEO of Kinnate, who was one of Pharmaceutical Executive’s Emerging Pharma Leaders in 2013, discusses how he’s successfully navigated his career path, from building a foundation in pharma to growing his expertise in biotech.

Pharma 52

Pharma Pharmaceutical 52

Pharmacy Times

DECEMBER 4, 2023

in 2013 to 19.3% The proportion of prescriptions by a 340B-affiliated physician increased from 9.4% in 2020, but the prescriptions filled by 340B pharmacies increased from 18.4% to 49.9%.

Prescription 48

Prescription Physicians 48

pharmaphorum

DECEMBER 12, 2022

He rose to the position of head of global product strategy at Roche in 2013, before taking the CEO role at Genentech in 2017 and then group head pharma in January 2019. There’s no word yet on where Anderson will continue his career, but a CEO role at a biotech company seems a likely destination.

Pharma 95

Pharma Management Pharmaceutical Marketing 95

European Pharmaceutical Review

JULY 28, 2023

Since 2013, Barr has worked as Senior Vice President, Head of Research and Product Development of Alexion, AstraZeneca’s rare disease group. She will work across Cardiovascular, Renal & Metabolism and Respiratory & Immunology.

Medicine 98

Medicine Patients Pharma Pharmaceutical 98

pharmaphorum

SEPTEMBER 13, 2022

Chiesi’s involvement with Lamzede dates back to 2013, when it acquired the drug’s original developer Zymenex and used it as the foundation for a protein-based therapeutics division. At the moment, almost three quarters of the Italian drugmaker’s turnover is in Europe, with 15% from the US and 13% from the rest of the world.

FDA 105

FDA Distribution Prospecting Patients 105

European Pharmaceutical Review

JULY 12, 2022

More than 480 warning letters solely related to the failure to produce aseptic conditions because of deficient cleaning and disinfection systems for cleanrooms and their equipment, were issued by regulators between 2013 to 2018. Microbial resistance is one of the factors responsible for such failings.

Pharmaceutical manufacturing 111

Pharmaceutical manufacturing Pharmaceutical Pharmaceutical research Manufacturing 111

European Pharmaceutical Review

NOVEMBER 2, 2023

The most recent guide was published by the WHO in 2013. The study, which was funded by the Wellcome Trust, also reveals the urgent need for global antibiotic guidelines to be updated, to reflect the rapidly evolving rates of AMR. The WHO has declared AMR as one of the top 10 global public health threats facing humanity.

Manufacturing 98

Manufacturing Leads Medical Pharmaceutical 98

PM360

JULY 26, 2022

A wide-ranging systematic review undertaken in 2013 identified a total of 771 individual factors influencing likelihood of non-adherence, clustering into socio-economic, healthcare team, system, condition, therapy, and patient-related factors.

Patients 105

Patients Medical Healthcare Healthcare 105

pharmaphorum

APRIL 10, 2017

Indeed, QuintilesIMS forecasts that, between 2013 and 2018, 94% of list price value growth will be in specialty medicines – with orphan drugs at the forefront of this trend.

Medicine 52

Medicine Pharmaceutical Marketing Patients 52

pharmaphorum

OCTOBER 28, 2022

Angela spent a decade in pharma sales and marketing management roles with MSD and BMS, prior to staring the world’s second market access agency in 1998, which she sold to IMS Health in 2013. She is an SME in market access, rare disease and biosimilars.

Medicine 122

Medicine Management Marketing Leads 122

European Pharmaceutical Review

JUNE 28, 2024

The Novartis-MIT project culminated in a 2013 publication describing an end-to-end continuous process to produce aliskiren drug substance, and formulated drug product, at pilot scale. For pharmaceuticals, the motivating factors likely include the desire for greater quality control, along with expected improvements in safety and efficiency.

Manufacturing 52

Manufacturing Safety Pharmaceutical 52

pharmaphorum

NOVEMBER 11, 2022

18% of study participants were Black/African American in 2013, but that contracted to 14% in 2020 and then plunged to just 9% in 2021. For Hispanics, participation in trials increased from 7% in 2012 to a high of just under 10% in 2017 but fell back to levels of around 8% to 9% in the past two years.

Recruitment 97

Recruitment Pharma Education FDA 97

pharmaphorum

OCTOBER 27, 2022

GSK licensed otilimab from German biotech MorphoSys in 2013 in a deal valued at up to €423 million, including around €23 million upfront. Daprodustat backed. There has been somewhat better news for GSK for another of its top pipeline prospects – renal anaemia drug daprodustat – although that also came with disappointment.

Side effects 97

Side effects FDA Patients Sales 97

Medico Reach

AUGUST 18, 2022

Founder: Tim Barry Year of Establishment: 2013 Headquarters: Chicago, Illinois. Founders: Ali Diab and Rajaie Batniji Year of establishment: 2013 Headquarters: San Mateo, California. As a matter of fact, Kyruus now connects around 300,000 medical providers with over 90 million members across the US. Collective Health.

Healthcare 98

Healthcare Healthcare Medical Doctors 98

Clarivate

JANUARY 23, 2024

Figure 1 illustrates the trend in the number of NMEs first launched onto the world market between 2013 and 2022. In fact, the number of NMEs has grown by 65% between 2013 and 2022. Looking at NMEs launched globally in 2022 paints a gloomy picture at first sight, with a 28% drop from 2021 to 2022.

Pharma 52

Pharma Sales Consulting Pharmaceutical 52

Clarivate

SEPTEMBER 27, 2022

Two Highly Cited Researchers, close in name but not location, collaborated on a 2013 Highly Cited Paper about China’s water policies and their socioeconomic, environmental and ecological impacts. Their 2013 paper has been cited 220 times. Integration of green and gray infrastructure for water management. However, unlike chemical (e.g.

Management 98

Management Government Pharmaceutical Networking 98

European Pharmaceutical Review

FEBRUARY 1, 2024

For at least a decade from 2013 until recently, LDL lowering treatments were stuck on a paradigm of just putting people on statins and not getting LDL levels down to certain goals” CETP inhibitors have been around for a while, but they have unfortunately been unsuccessful in getting onto the market commercially. “For

Pharma 97

Pharma Patients Pharmaceutical Leads 97

European Pharmaceutical Review

OCTOBER 2, 2023

Key developments: mRNA vaccines and therapeutics Katalin Karikó In 1989, Katalin Karikó was appointed Assistant Professor at the University of Pennsylvania, where she stayed until 2013. Following this tenure, she became Vice President and later Senior Vice President at BioNTech RNA Pharmaceuticals.

Medicine 111

Medicine Pharmaceutical Pharma Leads 111

PM360

NOVEMBER 29, 2022

1, 2013. Using these outreach channels can empower patients to access the care they need to address constipation symptoms that have often compromised their lives for years, and in doing so, help them realize the unfulfilled potential of prescription constipation therapies. References: 1.

Patients 98

Patients Prescription Doctors Education 98

PM360

SEPTEMBER 20, 2024

To see all this years Winners please visit: [link] For more information and sponsorship opportunities: Peter Beattie, Awards Director: awards@thecreativefloor.com About The Creative Floor The Creative Floor Healthcare Awards was founded in 2013 by Shaheed Peera. The aim was to help change the way award shows are run.

Healthcare 52

Healthcare Healthcare Specialization Networking 52